|
METTL4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.8891599999904E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.14399999999282E-05 |
| Normal-vs-Stage2 |
1.621030E-03 |
| Normal-vs-Stage3 |
1.780960E-03 |
| Normal-vs-Stage4 |
1.658360E-03 |
| Stage1-vs-Stage2 |
9.611400E-01 |
| Stage1-vs-Stage3 |
6.659400E-01 |
| Stage1-vs-Stage4 |
4.838800E-01 |
| Stage2-vs-Stage3 |
7.197000E-01 |
| Stage2-vs-Stage4 |
4.665200E-01 |
| Stage3-vs-Stage4 |
7.324600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.40169999999873E-05 |
| Normal-vs-AfricanAmerican |
4.567100E-04 |
| Normal-vs-Asian |
5.997700E-02 |
| Caucasian-vs-AfricanAmerican |
8.066400E-01 |
| Caucasian-vs-Asian |
8.727600E-01 |
| AfricanAmerican-vs-Asian |
7.948400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.55370000000099E-05 |
| Normal-vs-Female |
2.837400E-03 |
| Male-vs-Female |
3.529200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.805600E-04 |
| Normal-vs-Extreme_Weight |
1.98269999999168E-05 |
| Normal-vs-Obese |
9.68300000000477E-05 |
| Normal-vs-Extreme_Obese |
5.959500E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.155000E-01 |
| Normal_Weight-vs-Obese |
8.356200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.730400E-01 |
| Extreme_Weight-vs-Obese |
9.733200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.796000E-01 |
| Obese-vs-Extreme_Obese |
9.634400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.340400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.200800E-04 |
| Normal-vs-Age(61-80Yrs) |
2.41449999999199E-05 |
| Normal-vs-Age(81-100Yrs) |
4.77580000002309E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.704800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.783600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.305900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.231600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.959900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.459700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.366100E-04 |
| Normal-VS-Type2 PRCC |
1.27670000016344E-07 |
| Normal-VS-KIRP CIMP |
2.169700E-02 |
| Normal-VS-Unclassified PRCC |
7.065000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.355200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.780800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.426600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.260200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.893600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.328200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.23649999999687E-05 |
| Normal-vs-N1 |
3.120300E-03 |
| Normal-vs-N2 |
5.356500E-03 |
| N0-vs-N1 |
4.704200E-01 |
| N0-vs-N2 |
4.277000E-01 |
| N1-vs-N2 |
2.995000E-01 |
|
|
